ArticleOncotarget2015

Simultaneous targeting of androgen receptor (AR) and MAPK-interacting kinases (MNKs) by novel retinamides inhibits growth of human prostate cancer cell lines.

Vidya P Ramamurthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.